Our last update on Oxford Instruments (OXIG), at the technology tools group's half-year results, was resolutely bearish. Currency movements may have been kind, but slowing academic funding in the US and a tepid healthcare market brought reasons for concern. And while full-year figures still point to a "challenging market backdrop", a post-period agreement to sell the industrial analysis business for £80m has clouded the picture, notwithstanding the shares' recent re-rating.
To continue reading, register today
to enjoy limited access to the following:
- Daily trading news
- Funds coverage
- Features on big investment themes
- Comprehensive companies coverage
- Economic analysis